Business Update

Pharmaceutical company mulling divestiture of Consumer Health Unit, market report says

Published in Biotech Business Week, March 20th, 2006

Some of the brands found in millions of Americans' medicine cabinets, including Listerine, Neosporin, and Sudafed, may soon be sold off once again. The future of Pfizer's Consumer Healthcare unit will be determined later as the company focuses attention on the future of its prescription drug business.

According to a report by Kline & Company, Pfizer, faced with the impending patent expirations for some of its key prescription medications, including Zyrtec, Zoloft, and Norvasc, as well as challenges to Lipitor's patent by generic competitors and safety issues with its COX-2 inhibitors Celebrex and Bextra, may need to invest more aggressively in filling its pipeline with...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2006-03-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry